Are albendazole and Emverm (mebendazole) the same medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Are Albendazole and Emverm the Same Medication?

No, albendazole and Emverm (mebendazole) are two distinct anthelmintic medications with different chemical structures, though they belong to the same benzimidazole drug class and treat similar intestinal worm infections. 1

Key Differences

Chemical Structure and Formulation

  • Albendazole is a benzimidazole anthelmintic typically dosed at 400 mg 2, 3
  • Emverm (mebendazole) is methyl 5-benzoylbenzimidazole-2-carbamate with molecular formula C16H13N3O3, available as 100 mg chewable tablets 1
  • These are chemically distinct compounds despite sharing the same drug class 1, 4

Comparative Efficacy Against Common Helminths

For Ascaris lumbricoides (roundworm):

  • Both drugs demonstrate excellent efficacy with cure rates exceeding 96% and egg reduction rates over 99% 5
  • Either albendazole 400 mg single dose or mebendazole 500 mg single dose is recommended 2

For Trichuris trichiura (whipworm):

  • Mebendazole shows superior efficacy with cure rates of 34.7% and egg reduction of 92.3% compared to albendazole's 13.9% cure rate and 63.4% egg reduction 5
  • Current guidelines recommend mebendazole 100 mg twice daily for 3 days combined with ivermectin 200 μg/kg daily for 3 days to improve cure rates 2
  • Single-dose regimens of either drug show limited efficacy against whipworm 6, 7

For hookworm (Ancylostoma/Necator):

  • Albendazole demonstrates superior efficacy with cure rates of 81.8% versus mebendazole's 17.2% when given as single doses 8
  • Albendazole 400 mg daily for 3 days is the recommended regimen for hookworm 2

Safety Profile Differences

  • Mebendazole appears safer with fewer adverse event complaints compared to albendazole 5
  • Both drugs are contraindicated in the first trimester of pregnancy 4
  • Mebendazole (Emverm) should not be taken with metronidazole due to risk of Stevens-Johnson syndrome and toxic epidermal necrolysis 1
  • Convulsions have been reported with mebendazole use in children less than one year of age 1

Clinical Decision Algorithm

Choose albendazole when:

  • Treating hookworm infections (superior efficacy) 8, 9
  • Single-dose therapy is preferred for Ascaris 2
  • Treating tissue parasites requiring prolonged therapy (hydatid disease, toxocariasis, neurocysticercosis) 10, 3

Choose mebendazole (Emverm) when:

  • Treating Trichuris trichiura (better efficacy than albendazole) 5
  • Patient is taking metronidazole (albendazole does not have this contraindication) 1
  • Fewer gastrointestinal side effects are desired 5

For mixed infections:

  • Either drug is acceptable for Ascaris 2, 5
  • Consider mebendazole if Trichuris is present 5
  • Consider albendazole if hookworm is present 8, 9

Common Pitfall to Avoid

Do not assume these medications are interchangeable based solely on their shared drug class. While both are benzimidazoles used for intestinal helminths, their efficacy profiles differ significantly for specific parasites, particularly hookworm (where albendazole is superior) and whipworm (where mebendazole performs better) 5, 8. The choice should be guided by the specific helminth infection being treated rather than treating them as equivalent alternatives.

References

Guideline

Albendazole Prescribing Guidelines for Helminth Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Albendazole and mebendazole administered alone or in combination with ivermectin against Trichuris trichiura: a randomized controlled trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.